1. Home
  2. HGBL vs CVM Comparison

HGBL vs CVM Comparison

Compare HGBL & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Global Inc.

HGBL

Heritage Global Inc.

HOLD

Current Price

$1.32

Market Cap

46.9M

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$4.19

Market Cap

41.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HGBL
CVM
Founded
1937
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.9M
41.2M
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
HGBL
CVM
Price
$1.32
$4.19
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
66.9K
43.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$20,129,000.00
$264,033.00
Revenue This Year
$16.03
N/A
Revenue Next Year
$5.33
N/A
P/E Ratio
$14.22
N/A
Revenue Growth
N/A
65.45
52 Week Low
$1.21
$0.18
52 Week High
$2.39
$13.48

Technical Indicators

Market Signals
Indicator
HGBL
CVM
Relative Strength Index (RSI) 48.06 37.74
Support Level $1.24 $4.01
Resistance Level $1.47 $6.71
Average True Range (ATR) 0.06 0.45
MACD -0.01 -0.05
Stochastic Oscillator 61.29 7.19

Price Performance

Historical Comparison
HGBL
CVM

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: